The U.S. FDA and HHS have recommended reclassifying cannabis from Schedule I to Schedule III, citing its low abuse potential…
The Drug Enforcement Administration (DEA) has asserted that it has the final say in the reclassification of cannabis amid discussions…
The DEA plans to significantly increase the production quotas of psychedelic substances such as psilocybin, ibogaine, and cannabis-related compounds like…
The U.S. Department of Health has recommended cannabis be downgraded from Schedule I to Schedule III on the Controlled Substances…
The DEA says two neo-cannabinoids that have recently appeared in various products sold in the US do not meet the…
The U.S. federal agency is currently proposing a new set of rules that would allow the development of scientific research…
The U.S. Drug Enforcement Agency (DEA) has reviewed 33 pending applications to plant marijuana for cannabis research. This comes after…
While hemp is now legalized on the federal level, there is still confusion, particularly among DEA officers, regarding the difference…
Since the legalization of hemp in the U.S., there has been confusion among the DEA officers regarding the differences between…
The United States’ Drug Enforcement Administration (DEA) made a ruling that removes CBD from the agency’s list of Schedule 1…